Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Abstract Text:

Atsushi Hashimoto,Izumi Hayashi,Yousuke Murakami,Yoshinori Sato,Hidero Kitasato,Reiko Matsushita,Nobuko Iizuka,Ken Urabe,Moritoshi Itoman,Shunsei Hirohata,Hirahito Endo,Atsushi Hashimoto,Izumi Hayashi,Yousuke Murakami,Yoshinori Sato,Hidero Kitasato,Reiko Matsushita,Nobuko Iizuka,Ken Urabe,Moritoshi Itoman,Shunsei Hirohata,Hirahito Endo,

OBJECTIVE: To evaluate the role of an antiinflammatory lipid mediator, lipoxin A4 (LXA4), in inflammatory arthritis, we measured the level of LXA4 in synovial fluid and lipoxin A4 receptor (ALX) expression in synovial tissues obtained from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). METHODS: Levels of LXA4 and its analog (15-epi-LXA4) in synovial fluid from 30 patients with RA and 15 patients with OA were measured by a specific ELISA. Reverse transcription-polymerase chain reaction (RT-PCR), real-time quantitative PCR, and in situ hybridization were performed to detect mRNA for ALX and 15-LOX, and LXA4 synthetase, in synovial tissues from 20 patients with RA and 10 patients with OA. RESULTS Both LXA4 and 15-epi-LXA4 showed significantly higher levels in RA synovial fluid (10.34 +/- 14.12 ng/ml for LXA4) than OA synovial fluid (0.66 +/- 0.77 ng/ml for LXA4). Logarithmic concentration of LXA4 was significantly correlated with that of leukotriene B4 and prostaglandin E2 in RA and OA synovial fluids. Expressions of ALX and 15-LOX mRNA were stronger in RA synovium than OA synovium. Expression of mRNA for interleukin 13 (IL-13), which induces 15-LOX, was significantly stronger in RA synovium than OA synovium. CONCLUSION: ALX is an important target of LXA4 in synovial tissues of patients with RA. 15-LOX induced by IL-13 might regulate the production of LXA4 to have an antiinflammatory effect against proinflammatory lipid mediators in inflamed joints. These findings could lead to the development of new therapy for inflammatory arthritis such as RA.

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Publishing Authors By Initials

A Hashimoto,I Hayashi,Y Murakami,Y Sato,H Kitasato,R Matsushita,N Iizuka,K Urabe,M Itoman,S Hirohata,H Endo,A Hashimoto,I Hayashi,Y Murakami,Y Sato,H Kitasato,R Matsushita,N Iizuka,K Urabe,M Itoman,S Hirohata,H Endo,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The Journal of rheumatology

VOLUME: 34

Page Numbers: 2144-53

Journal Abbreviation: J. Rheumatol.

ISSN: 0315-162X

DAY: 1

MONTH: 10

YEAR: 2007

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7501984

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.

AFFILIATION: Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, Japan. hashi@med.kitasato-u.ac.jp

Country: Canada

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Rheumatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis Related Publications

• A Possible treatment strategy and clinical factors to estimate the treatment response in Bebesia gibsoni infection.
• Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
• Comparative characterization study of microporous carbons by HRTEM image analysis and gas adsorption.
• Cystic teratoma of the diaphragm which mimicked soft tissue lipoma.
• Design of new phosphonic acid monomers for dental adhesives--synthesis of (meth) acryloxyalkyl 3-phosphonopropionates and evaluation of their adhesion-promoting functions.
• Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
• Effects of intrafractional motion on water equivalent pathlength in respiratory-gated heavy charged particle beam radiotherapy.
• Electron paramagnetic resonance and optical absorption spectral studies on chalcocite.
• Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.
• Four cases of chemical burns thought to be caused by exposure to chromic acid mist.
• Impact of anomalous origin of the ophthalmic artery from the middle meningeal artery on selection of surgical approach to skull base meningioma.
• In situ small-angle neutron scattering and rheological measurements of shear-induced gelation.
• Indomethacin solubilization induced shape transition in C(n)E(7) (n=14,16) nonionic micelles.
• Intermolecular potential energy surface of Ar-NO.
• Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.
• Laser induced fluorescence spectroscopy of the C(3)N radical.
• Malignant transformation of clival chordoma after gamma knife surgery - case report - .
• Molecular aggregates of partially fluorinated quaternary ammonium salt gemini surfactants.
• Multi-purpose bonding performance of newly synthesized phosphonic acid monomers.
• Multiple meningiomas consisting of fibrous meningioma and anaplastic meningioma.
• Oral bacterial lipopolysaccharide acts in mice to promote sensitisation to ovalbumin and to augment anaphylaxis via platelets.
• Ossifying fibromyxoid tumor of soft parts with clonal chromosomal aberrations.
• Preliminary study: color map of hepatocellular carcinoma using dynamic contrast-enhanced 256-detector row CT.
• Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases.
• The alpha/beta Interfaces of alpha1beta1, alpha3beta3, and F1: Domain Motions and Elastic Energy Stored during gamma Rotation.
• Three-dimensional, Computer-tomographic Analysis of Membrane Proteins (TrkA, caveolin, clathrin) in PC12 Cells.
• Thrombin-induced cell proliferation and platelet-derived growth factor-AB release from A172 human glioblastoma cells.
• [Clinical use of nuclear medicine in the management of thyroid disease]
• [Epidemiology of dyspepsia and its therapeutic approach. Clinical practice starts with good relationship with patients]
• cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor.